Brucellosis vaccines for livestock.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Veterinary Immunology and Immunopathology

• Publication date

  2016-11-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.vetimm.2016.03.011PMID 27032465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nasal Vaccination Stimulates CD8+ T Cells for Potent Protection Against Mucosal Brucella melitensis Challenge

  2016cited by this paper
• Immune Responses of Bison and Efficacy after Booster Vaccination with Brucella abortus Strain RB51

  2015cited by this paper
• Improved Serodiagnosis of Bovine Brucellosis by Novel Synthetic Oligosaccharide Antigens Representing the Capping M Epitope Elements of Brucella O-Polysaccharide

  2015cited by this paper
• Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.

  2015cited by this paper
• Immune response triggered by Brucella abortus following infection or vaccination.

  2015cited by this paper
• Brucella suis infection in domestic pigs in Sardinia (Italy)

  2014cited by this paper
• Clinical manifestations, complications, and treatment of brucellosis: evaluation of 72 cases.

  2014cited by this paper
• Bovine brucellosis in Argentina and bordering countries: update.

  2014cited by this paper
• Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection

  2014cited by this paper
• Vaccination of adult animals with a reduced dose of Brucella abortus S19 vaccine to control brucellosis on dairy farms in endemic areas of India

  2014cited by this paper
• Humoral Immunity and CD4+ Th1 Cells Are Both Necessary for a Fully Protective Immune Response upon Secondary Infection with Brucella melitensis

  2014cited by this paper
• Oral Immunization of Mice with Gamma-Irradiated Brucella neotomae Induces Protection against Intraperitoneal and Intranasal Challenge with Virulent B. abortus 2308

  2014cited by this paper
• Brucella melitensis with Immune Response upon Secondary Infection Both Necessary for a Fully Protective Th1 Cells Are + Humoral Immunity and CD4

  2014cited by this paper
• Molecular characterisation of Brucella species.

  2013cited by this paper
• Feral swine brucellosis in the United States and prospective genomic techniques for disease epidemiology.

  2013cited by this paper
• Intranasal Immunization of Lambs with Serine/Threonine Phosphatase 2A against Gastrointestinal Nematodes

  2013cited by this paper
• Recent developments in livestock and wildlife brucellosis vaccination.

  2013cited by this paper
• Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis

  2013cited by this paper
• Brucellosis in terrestrial wildlife.

  2013cited by this paper
• Progress in Brucella vaccine development

  2013cited by this paper
• Update on the role of innate immune receptors during Brucella abortus infection.

  2012cited by this paper
• Neglected Tropical Diseases of the Middle East and North Africa: Review of Their Prevalence, Distribution, and Opportunities for Control

  2012cited by this paper
• What have we learned from brucellosis in the mouse model?

  2012cited by this paper
• Efficacy of Dart or Booster Vaccination with Strain RB51 in Protecting Bison against Experimental Brucella abortus Challenge

  2012cited by this paper
• Control and eradication of Brucella melitensis infection in sheep and goats.

  2011cited by this paper
• Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.

  2011cited by this paper
• Comparative analysis of the early transcriptome of Brucella abortus--infected monocyte-derived macrophages from cattle naturally resistant or susceptible to brucellosis.

  2011cited by this paper
• Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century.

  2011cited by this paper
• Representative Seroprevalences of Brucellosis in Humans and Livestock in Kyrgyzstan

  2011cited by this paper
• DNA VACCINATION OF BISON TO BRUCELLAR ANTIGENS ELICITS ELEVATED ANTIBODY AND IFN-γ RESPONSES

  2011cited by this paper
• Protective Live Oral Brucellosis Vaccines Stimulate Th1 and Th17 Cell Responses

  2011cited by this paper
• Importance of Lipopolysaccharide and Cyclic β-1,2-Glucans in Brucella-Mammalian Infections

  2010cited by this paper
• DeltaznuADeltapurE Brucella abortus 2308 mutant as a live vaccine candidate.

  2010cited by this paper
• Brucellosis: a re-emerging zoonosis.

  2010cited by this paper
• Diagnosis of brucellosis in livestock and wildlife.

  2010cited by this paper
• Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.

  2010cited by this paper
• Pathogenesis of bovine brucellosis.

  2010cited by this paper
• Pathological, immunohistochemical and bacteriological study of tissues and milk of cows and fetuses experimentally infected with Brucella abortus.

  2009cited by this paper
• Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host

  2009cited by this paper
• ORAL VACCINATION WITH MICROENCAPSULED STRAIN 19 VACCINE CONFERS ENHANCED PROTECTION AGAINST BRUCELLA ABORTUS STRAIN 2308 CHALLENGE IN RED DEER (CERVUS ELAPHUS ELAPHUS)

  2009cited by this paper
• Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens.

  2009cited by this paper
• What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?

  2009cited by this paper
• A Combined DNA Vaccine Provides Protective Immunity Against Mycobacterium bovis and Brucella abortus in Cattle

  2009cited by this paper
• Immune Responses and Protection against Experimental Challenge after Vaccination of Bison with Brucella abortus Strain RB51 or RB51 Overexpressing Superoxide Dismutase and Glycosyltransferase Genes

  2009cited by this paper
• ENHANCED IMMUNE RESPONSE OF RED DEER (CERVUS ELAPHUS) TO LIVE RB51 VACCINE STRAIN USING COMPOSITE MICROSPHERES

  2009cited by this paper
• Brucellosis.

  2008cited by this paper
• Protection levels in vaccinated heifers with experimental vaccines Brucella abortus M1-luc and INTA 2.

  2008cited by this paper
• DNA vaccines and their applications in veterinary practice: current perspectives

  2008cited by this paper
• Design opportunities for actively targeted nanoparticle vaccines.

  2008cited by this paper
• The role of innate immune receptors in the control of Brucella abortus infection: toll-like receptors and beyond.

  2008cited by this paper
• Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

  2008cited by this paper
• Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.

  2008cited by this paper
• Veterinary vaccines and their use in developing countries.

  2007cited by this paper
• Virulence factors in brucellosis: implications for aetiopathogenesis and treatment

  2007cited by this paper
• Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.

  2007cited by this paper
• Solid lipid nanoparticles as a drug delivery system for peptides and proteins.

  2007cited by this paper
• Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.

  2007cited by this paper
• Persistence and relapse in brucellosis and need for improved treatment.

  2007cited by this paper
• A Bile Salt Hydrolase of Brucella abortus Contributes to the Establishment of a Successful Infection through the Oral Route in Mice

  2006cited by this paper
• Immune Responses of Elk to Initial and Booster Vaccinations with Brucella abortus Strain RB51 or 19

  2006cited by this paper
• Deletion of znuA Virulence Factor Attenuates Brucella abortus and Confers Protection against Wild-Type Challenge

  2006cited by this paper
• The new global map of human brucellosis.

  2006cited by this paper
• Effective treatments in the management of brucellosis

  2005cited by this paper
• Innate immune responses during infection.

  2004cited by this paper
• Brucellosis and international travel.

  2004cited by this paper
• Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.

  2004cited by this paper
• Alternative routes of mucosal immunization in large animals

  2004cited by this paper
• Rough vaccines in animal brucellosis: structural and genetic basis and present status.

  2004cited by this paper
• Immunology, Infection, and Immunity

  2004cited by this paper
• Oral Vaccination with Brucella melitensis WR201 Protects Mice against Intranasal Challenge with Virulent Brucella melitensis 16M

  2004cited by this paper
• Induction of immune responses by DNA vaccines in large animals.

  2003cited by this paper
• Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis.

  2003cited by this paper
• Brucella Evades Macrophage Killing via VirB-dependent Sustained Interactions with the Endoplasmic Reticulum

  2003cited by this paper
• BRUCELLA ABORTUSSTRAIN RB51 VACCINATION IN ELK II. FAILURE OF HIGH DOSAGE TO PREVENT ABORTION

  2002cited by this paper
• The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae

  2002cited by this paper
• Brucella vaccines in wildlife.

  2002cited by this paper
• SAFETY OF BRUCELLA ABORTUS STRAIN RB51 VACCINE IN NON-TARGET UNGULATES AND COYOTES

  2002cited by this paper
• Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves.

  2001cited by this paper
• Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle.

  2001cited by this paper
• Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.

  2001cited by this paper
• Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.

  2000cited by this paper
• Overexpression of Protective Antigen as a Novel Approach To Enhance Vaccine Efficacy of Brucella abortusStrain RB51

  2000cited by this paper
• Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.

  1998cited by this paper
• Bovine type 1 and type 2 responses.

  1998cited by this paper
• Bacterial Survival, Lymph Node Pathology, and Serological Responses of Bison (Bison bison) Vaccinated with Brucella abortus Strain RB51 or Strain 19

  1997cited by this paper
• Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response.

  1997cited by this paper
• A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.

  1997cited by this paper
• Abortion and placentitis in pregnant bison (Bison bison) induced by the vaccine candidate, Brucella abortus strain RB51.

  1996cited by this paper
• Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production

  1995cited by this paper
• Characteristics of and risk factors for relapse of brucellosis in humans.

  1995cited by this paper
• Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51

  1994cited by this paper
• Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide.

  1993cited by this paper
• Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev 1 vaccine: safety and serological responses.

  1992cited by this paper
• BRUCELLA ABORTUS IN BISON. II. EVALUATION OF STRAIN 19 VACCINATION OF PREGNANT COWS

  1991cited by this paper
• Biological properties of RB51; a stable rough strain of Brucella abortus.

  1991cited by this paper
• Pathogenesis of Placentitis in the Goat Inoculated with Brucella abortus. I. Gross and Histologic Lesions

  1986cited by this paper
• Lung lesions in bovine fetuses aborted by Brucella abortus.

  1984cited by this paper
• Vaccination of cattle with Brucella abortus strain 19 administered by differing routes and doses.

  1984cited by this paper
• Protection by oral administration of brucella abortus strain 19 against an oral challenge exposure with a pathogenic strain of Brucella.

  1983cited by this paper
• THE RELATION OF ERYTHRITOL USAGE TO VIRULENCE IN THE BRUCELLAS.

  1964cited by this paper

• Assessment of the awareness, knowledge, and practices of smallholder farmers for brucellosis prevention at Geita periurban, Tanzania

  2026cites this paper
•  Brucellosis Management in Dairy Cattle Farms: Reviewing Programs and Addressing Challenges in Iranian Dairy Cattle Farms

  2025cites this paper
• Genetic Characterization of Brucella Species in Some Dairy Farms of the Nile Delta, Egypt

  2025cites this paper
• Case report: brucellosis with fever and eye pain as first symptoms

  2025cites this paper
• Infectious eye disease in the 21st century—an overview

  2024cites this paper
• Strategies for Combatting Brucellosis: A Review on Control and Prevention in Bovines

  2024cites this paper
• Immunogenic Consideration of a Designed Polypeptide Against Brucellosis Compared to RB51: An In Vivo Study

  2024cites this paper
• Efficacy of Brucella Vaccines in Sheep: A Systematic Review and Meta-Analysis

  2024cites this paper
• Development of a Plant-Expressed Subunit Vaccine against Brucellosis

  2024cites this paper
• A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection

  2023cites this paper
• Seroprevalence and related risk factors of Brucella spp. in livestock and humans in Garbatula subcounty, Isiolo county, Kenya

  2023cites this paper
• Shedding rate of Brucella spp. in the milk of seropositive and seronegative dairy cattle

  2023cites this paper
• Immune response and recent advances in diagnosis and control of brucellosis

  2022cites this paper
• Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis

  2022influential citation
• Detection of Brucella S2 vaccine strain by a loop-mediated isothermal amplification (LAMP) method

  2022cites this paper
• Live mucosal vaccination stimulates potent protection via varied CD4+ and CD8+ T cell subsets against wild-type Brucella melitensis 16M challenge

  2022cites this paper
• Brucellosis in Humans and Animals in Kyrgyzstan

  2022cites this paper
• Evaluation of the Fluorescence Polarization Assay for the Diagnosis of Brucellosis in Goat Milk

  2022cites this paper
• Generation and Selection of Specific Aptamers Targeting Brucella Species through an Enhanced Cell-SELEX Methodology

  2022cites this paper
• Cobalt (II) Chloride Regulates the Invasion and Survival of Brucella abortus 544 in RAW 264.7 Cells and B6 Mice

  2022cites this paper
• Proteomic and Antibody Profiles Reveal Antigenic Composition and Signatures of Bacterial Ghost Vaccine of Brucella abortus A19

  2022cites this paper
• Brucellosis control methods with an emphasis on vaccination: a systematic review

  2022influential citation
• Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model

  2022cites this paper
• Study on immunogenicity and antigenicity of a novel brucella multiepitope recombined protein.

  2021cites this paper
• Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.

  2021cites this paper
• Improvement of the attenuated mutant strain of Brucella melitensis Rev1 as a potential vaccine candidate

  2021cites this paper
• Infectious Agents

  2021cites this paper
• Bayesian Estimation of the Prevalence and Test Characteristics (Sensitivity and Specificity) of Two Serological Tests (RB and SAT-EDTA) for the Diagnosis of Bovine Brucellosis in Small and Medium Cattle Holders in Ecuador

  2021cites this paper
• Epitope-Based Vaccine of a Brucella abortus Putative Small RNA Target Induces Protection and Less Tissue Damage in Mice

  2021cites this paper
• The State of the Art in Biodefense Related Bacterial Pathogen Detection Using Bacteriophages: How It Started and How It’s Going

  2020cites this paper
• Frequency of reproductive impact diseases in dual-purpose cattle located in Oaxaca , Mexico

  2020cites this paper
• An estimate of the incidence and quantitative risk assessment of human brucellosis in mainland China.

  2020cites this paper
• Comparative Field Trial Effect of Brucella spp. Vaccines on Seroconversion in Goats and Their Possible Implications to Control Programs

  2020cites this paper
• Synthetic carbohydrate-based vaccines: challenges and opportunities

  2020cites this paper
• A novel recombinant multiepitope protein candidate for the diagnosis of brucellosis: A pilot study.

  2020cites this paper
• A safe non-toxic Brucella abortus ghosts induce immune responses and confer protection in BALB/c mice.

  2020cites this paper
• Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology

  2020cites this paper
• Immune response in creole goats vaccinated with the Brucella melitensis REV 1 vaccine applied by the conjunctival route.

  2020cites this paper
• Research progress on brucellosis.

  2019cites this paper
• Prevalence and economic losses of calf fetal wastage in ELAKAT public slaughterhouse of Bukavu, Democratic Republic of Congo

  2019cites this paper
• Brucellosis in India: results of a collaborative workshop to define One Health priorities

  2019cites this paper
• Antigenicity and Potential Use of A Novel Brucella Multiepitope Recombinant Protein in the Diagnosis of Brucellosis

  2019cites this paper
• Identification of Cross-Protective Potential Antigens against Pathogenic Brucella spp. through Combining Pan-Genome Analysis with Reverse Vaccinology

  2018cites this paper
• Development of new generation of vaccines for Brucella abortus

  2018cites this paper
• Immunogenicity of Recombinant Adenovirus Co-expressing the L 7 / L 12 and BCSP 31 Proteins of Brucella abortus

  2018cites this paper
• Risk factors of brucellosis (re-)incidence in sheep and goat flocks in an endemic area of Portugal

  2018cites this paper
• Evaluation of DNA vaccine encoding BCSP31 surface protein of Brucella abortus for protective immunity.

  2018cites this paper
• Herd-level risk factors associated with Brucella sero-positivity in cattle, and perception and behaviours on the disease control among agro-pastoralists in Tanzania.

  2018cites this paper
• Comparative experimental study of Brucella melitensis and its lipopolysaccharide in mouse model infected via subcutaneous route of exposure.

  2018cites this paper
• Protective role of Brucella abortus specific murine antibodies in inhibiting systemic proliferation of virulent strain 544 in mice and guinea pig

  2018cites this paper
• The Influence of Vaccine on Febrile Seizure

  2017cites this paper
• Changing Epidemiology of Human Brucellosis, China, 1955–2014

  2017cites this paper
• The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.

  2017cites this paper
• Brucellosis in livestock in and near the Maasai Mara national reserve in Kenya

  2017influential citation
• Novel Solutions for Vaccines and Diagnostics To Combat Brucellosis

  2017cites this paper
• A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M

  2017cites this paper
• Alternative strategies for vaccination to brucellosis.

  2017influential citation
• Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans

  2017cites this paper
• Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.

  2016cites this paper
• Brucella contamination in raw milk by polymerase chain reaction

  2016cites this paper